FORUM Sir Colin Dollery Lecture

The Academy’s annual FORUM Sir Colin Dollery Lecture recognises a key individual(s) working at the interface of academia, industry and healthcare and provides an opportunity to promote discussion amongst FORUM members, Academy Fellows and invited guests.

Since 2021, the Lecture has been named in memory of Sir Colin Dollery FMedSci’s contribution to biomedical and health research and his family’s commitment of long-term financial support for this event. 

2023 - How to innovate in health: applying implementation sciences

Professor Jo Rycroft-Malone OBE, Executive Dean of the Faculty of Health and Medicine at Lancaster University. 

Panel participants:

• Professor Dame Helen Stokes-Lampard DBE, Professor of GP Education, University of Birmingham & Member of the External Advisory Board to the UK AI Safety Institute
• Linda Parton, Member of the Lay Involvement and Knowledge Mobilisation (LINK) Group, Impact Accelerator Unit, Keele University
• Dr Edward Piper, Medical & Scientific Affairs Director, AstraZeneca
• Roland Sinker CBE, Chief Executive, Cambridge University Hospitals NHS Foundation Trust & National Director, NHS England

2022 - Pharmacogenomics, personalisation and public health

Professor Dan Roden, Senior Vice President of Personalised Medicine, Vanderbilt University

Panel participants and other speakers:

• Professor Sir Munir Pirmohamed FMedSci, David Weatherall Chair of Medicine, University of Liverpool (chair)
• Jane Burns, Member of the Drug Safety Patient & Public Involvement (PPI) Group, Wolfson Centre for Personalised Medicine
• Professor Katherine Payne, Professor of Health Economics, University of Manchester & registered Pharmacist
• Dr Richard Turner, Director - Physician in Genomic Sciences, GlaxoSmithKline
• Professor Bill Newman, Professor of Translational Genomic Medicine, University of Manchester

2021 - Celebrating the UK's scientific contributions to tackling the pandemic

Talks by speakers including:

• Professor Charlotte Summers, Professor of Intensive Care Medicine, University of Cambridge
• Professor Natalie Pattison, Professor of Clinical Nursing, University of Hertfordshire
• Mr Jacob Haddad, Co-Founder, accuRx
•  Dr Dave Triska, GP Partner, Witley and Milford Medical Partnership
• Professor Patrick Chinnery FMedSci, Professor of Neurology & Head of the Department of Clinical Neurosciences at University of Cambridge, and Chair of the National Core Study on Clinical Trials and of the UK COVID-19 Therapeutics Advisory Panel
•  Kimberley Featherstone, RECOVERY trial participant
•  Dr Melanie Saville, Director of Vaccine Research & Development, Coalition for Epidemic Preparedness Innovations
• Dr Waseem Bani, Junior Doctor, North West England; National COVID Response Group, British Islamic Medical Association (BIMA)

A panel discussion including:

• Sir Patrick Vallance FRS FMedSci, Chief Scientific Adviser to HM Government (chair)
• Professor Kamlesh Khunti FMedSci, Professor of Primary Care Diabetes & Vascular Medicine, University of Leicester
• Lynn Laidlaw, Co-chair, Patient and Care Reference Group, Academy of Medical Sciences’ COVID-19: preparing for the future report.
• Dame June Raine CBE, Chief Executive, Medicines and Healthcare products Regulatory Agency 
• Dr Najeeb Rahman, Consultant in Emergency Medicine, Leeds Teaching Hospitals NHS Trust; Member, National COVID Response Group, BIMA;Trustee, Doctors Worldwide; Founder, Frontline Collaboration Against COVID-19

2020 - Technology to support the sustainability of health and social care systems

Professor John Rogers, Louis Simpson and Kimberly Querrey Professor of Materials Science and Engineering, Biomedical Engineering and Medicine, Northwestern University

Panel participants:

• Dr Pearse Keane, UKRI Future Leaders Fellow, Institute of Ophthalmology, University College London and Consultant Ophthalmologist, Moorfields Eye Hospital
• Dr Karyn Morrissey, Senior Lecturer in the European Centre for Environment and Human Health, University of Exeter
• Dr Keith Grimes, Medical Director, Babylon Health

2019 - The promise of human genome editing for rare and genetic disease

Dr John Leonard, Chief Executive Officer, Intellia Therapeutics

Panel participants:

• Dr Mathew Garnett, Group Leader, Wellcome Sanger Institute
• Dr Nicola McCarthy, Business Unit Manager, Horizon Discovery
• Dr Alison Kay, Patient representative
• Dr Sarah Chan, Chancellor's Fellow, University of Edinburgh

2018 -Transforming healthcare through engineering and technology

Dr Omar Ishrak, Chair and Chief Executive Officer, Medtronic

Panel participants:

• Professor Alison Noble OBE FRS FREng, Professor of Biomedical Engineering, University of Oxford
• Professor Sebastien Ourselin, Head of the School of Biomedical Engineering & Imaging Sciences, King's College London
• Professor Lionel Tarassenko CBE FREng FMedSci, Chair in Electrical Engineering, University of Oxford
• Professor Chris Taylor OBE FREng, Professor of Medical Biophysics and Professor of Computer Science, University of Manchester

2017 - The mind-body interface
Professor Kevin Tracey, President and CEO, The Feinstein Institute for Medical Research

Panel participants:

• Professor Ed Bullmore, Head of Department of Psychiatry, University of Cambridge
• Professor Matthew Hotopf, Professor General Hospital Psychiatry, King's College London
• Professor Brenda Penninx, Professor of Psychiatric Epidemiology, EMGO Institute for Health and Care Research, VU University Medical Center Amsterdam
• Melissa Smith, Ophthalmology nurse and service user, East Sussex Healthcare NHS Trust

 2016 - What can research do to improve productivity in the NHS?
Dame Julie Moore, Chief Executive, University Hospitals Birmingham NHS Foundation Trust

Panel participants:

• Dr Annette Doherty OBE, Senior Vice President of Product Development, GlaxoSmithKline
• Dr Nicolaus Henke, Director of Healthcare Systems and Services Practice, McKinsey & Company
• Rt Hon Stephen Dorrell, Chair, NHS Confederation and Senior Adviser, KPMG
• Professor Sir Simon Wessely FMedSci, Chair of Psychological Medicine, King's College London and President, Royal College of Psychiatrists

2015 - A vision for the life sciences sector
Mr George Freeman MP, Parliamentary Under Secretary of State for Life Sciences

• Professor Sir John Bell GBE FRS HonFREng FMedSci, Regius Professor of Medicine, University of Oxford
• Mr Chris Brinsmead CBE, Life Sciences Business Adviser
• Mr John Jeans CBE, Chairman of Imanova, Chair of Cardiff University, Chair of UK Biocentre

2014 - Horizon scanning: looking ahead to 2025

• Sir Gordon Duff, Chairman, Medicines and Healthcare Products Regulatory Agency
• Professor Sir Malcolm Grant, Chair, NHS England
• Professor Dame Nancy Rothwell, President and Vice- Chancellor, University of Manchester
• Professor Patrick Vallance, President, Pharmaceuticals R&D, GSK

2013 - The changing pharmaceutical industry and the opportunity for precision medicine
Dr Ruth McKernan, Senior Vice President at Pfizer and Chief Scientific Officer at Neusentis

2012 - Frameworks of the Regulation of Medicinal Products: Opportunities and Challenges
Sir Alasdair Breckenridge CBE FRSE FMedSci, Chairman, MHRA

2011 - China's recent transformation into a major centre of medical research and innovation
Dr Jingwu Zang, Senior Vice President and Head of R&D China, GlaxoSmithKline

2010 - The importance of regulatory science to the healthcare portfolio
Dr Margaret Hamburg, Commissioner, Food and Drug Administration

2009 - UK life sciences - ensuring a healthy future
Lord Drayson of Kensington, Minister of State for Science & Innovation

2008 - The UK pharmaceutical industry - what does the future hold?
Andrew Witty, CEO Designate, GlaxoSmithKline

2007 - The highs and lows of academic-industrial collaborations
Professor Dame Nancy Rothwell FRS FMedSci

2006 - The human genome - realising the pharmaceutical opportunities
Dr Tim Rolph, Head of Discovery, Sandwich Laboratories, Pfizer Global R&D

2005 - Cancer research in the UK - areas of optimism & concern
Professor Alex Markham FMedSci, Chief Executive, Cancer Research UK

2004 - Can Europe compete in biomedical research?
Sir Tom McKillop, Chief Executive, AstraZeneca

2003 - Pharmacogenetics and personalised medicine
Dr Allen Roses, Senior Vice President, Genetics Research & Development, GlaxoSmithKline, North Carolina
 

The success of the FORUM events programme relies on supporter organisations who make an annual donation. These donations enable the Academy to deliver its FORUM programme of high-profile meetings, including the Lecture. To discuss how your organisation can join the network of FORUM supporters, please contact forum@acmedsci.ac.uk.